Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07PSW
|
||||
Former ID |
DNC004077
|
||||
Drug Name |
N-(4-Phenyl-pyridin-2-yl)-guanidine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C12H12N4
|
||||
Canonical SMILES |
C1=CC=C(C=C1)C2=CC(=NC=C2)N=C(N)N
|
||||
InChI |
1S/C12H12N4/c13-12(14)16-11-8-10(6-7-15-11)9-4-2-1-3-5-9/h1-8H,(H4,13,14,15,16)
|
||||
InChIKey |
LQYVUDQYWIIZAV-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Tissue-type plasminogen activator | Target Info | Inhibitor | [1] | |
KEGG Pathway | Complement and coagulation cascades | ||||
Transcriptional misregulation in cancer | |||||
NetPath Pathway | IL5 Signaling Pathway | ||||
PANTHER Pathway | Blood coagulation | ||||
Plasminogen activating cascade | |||||
Pathway Interaction Database | amb2 Integrin signaling | ||||
Beta2 integrin cell surface interactions | |||||
PathWhiz Pathway | Coagulation | ||||
Reactome | Dissolution of Fibrin Clot | ||||
WikiPathways | Senescence and Autophagy in Cancer | ||||
Complement and Coagulation Cascades | |||||
Endochondral Ossification | |||||
Blood Clotting Cascade | |||||
Dissolution of Fibrin Clot | |||||
Folate Metabolism | |||||
Vitamin B12 Metabolism | |||||
Selenium Micronutrient Network | |||||
References | |||||
REF 1 | Bioorg Med Chem Lett. 2002 Jan 21;12(2):181-4.Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 1: 2-Pyridinylguanidines. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.